JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 8 1324-1331
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nachar, O.
Right arrow Articles by van Lier, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nachar, O.
Right arrow Articles by van Lier, J. E.

Scintimammography with 11ß-Methoxy-(17{alpha},20Z)-[123I]Iodovinylestradiol: A Complementary Role to 99mTc-Methoxyisobutyl Isonitrile in the Characterization of Breast Tumors

Oussama Nachar, Jacques A. Rousseau, René Ouellet, André Rioux, Bernard Lefebvre, Hasrat Ali and Johan E. van Lier

Department of Nuclear Medicine and Radiobiology and Department of Surgery, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada

Correspondence: For correspondence or reprints contact: Johan E. van Lier, PhD, Department of Nuclear Medicine and Radiobiology, Faculty of Medicine, University de Sherbrooke, 3001,12th Ave. N., Sherbrooke, Quebec, Canada J1H 5N4.

ABSTRACT

The aim of this study was to investigate a possible relationship between 99mTc-methoxyisobutyl isonitrile (MIBI) uptake and the estrogen receptor (ER) status of breast tumors as determined by 11ß-methoxy-(17{alpha},20Z)-[123I]iodovinylestradiol (MIVE) scintimammography. Methods: Thirteen patients referred for MIVE scintimammography after abnormal mammography or finding of a suspect mass on physical examination were injected intravenously with MIVE. Planar images of the breasts and axillary region were taken with both radiopharmaceuticals and compared with pathologic examination of the tumor tissue and in vitro ER quantification. Results: The presence of cancerous tissue, as indicated by MIBI uptake, is a prerequisite for the accumulation of MIVE by the breast tumors. There was no statistically significant correlation between the MIBI and MIVE tumor uptake ratios. However, the latter correlate well with the presence of ER, as determined by an in vitro assay. Conclusion: MIVE scans add unique information concerning the tumor ER status in breast cancer patients, which could contribute to a better characterization of the tumor and aid in the selection of the most appropriate treatment protocol.

Key Words: estrogen receptors • iodovinylestradiol • MIVE • 123I • breast cancer • MIBI




This article has been cited by other articles:


Home page
ImagingHome page
J R Buscombe
Scintimammography
Imaging, September 1, 2001; 13(3): 164 - 170.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.